Results 141 to 150 of about 311,985 (405)

5‐Methylcytosine Analysis of miRNAs in Minimal Change Disease

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Minimal change disease (MCD) is a glomerular disorder, which is the most common cause of nephrotic syndrome in children. Additionally, the prevalence of MCD in adults has been increasing in recent years. During protein synthesis, noncoding RNAs can be regulated through a variety of modifications, which helps preserve biological diversity and ...
Huiyi Zeng, Dandan Li, Yunyi Li, Chen Yun, Xinzhou Zhang, Wenyu Gong, Mengyun Xiao, Haitao Li, Zhipeng Zeng, Ruqi Tan, Yishen Yang, Shaodong Luan, Yong Dai, Lianghong Yin, Donge Tang   +14 more
wiley   +1 more source

Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients

International Journal of Preventive Medicine, 2013
Background: Immunoglobulin A nephropathy (IgAN) with nephrotic syndrome is an uncommon form of IgAN. Clinical and morphological characteristics of proteinuria in IgAN, especially when is in nephrotic range have not yet been fully examined. This study was
Hamid Nasri, Yahya Madihi, Alireza Merrikhi, Allaleh Gheissari, Azar Baradaran, Soleiman Kheiri, Mahmoud Rafieian-Kopaei   +6 more
doaj  

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

When Blood Proteins Reveal What Transcripts Miss: Immune Cell Priming and the Road to Prognostic Biomarkers in Lupus

Arthritis &Rheumatology, EarlyView.
Ioannis Parodis
wiley   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Voclosporin‐induced gingival enlargement: A case report

Clinical Advances in Periodontics, EarlyView.
Abstract Background Drug‐influenced gingival enlargement (DIGE) is a recognized adverse effect of certain medications, particularly immunosuppressants like cyclosporin and tacrolimus. However, there have been no documented cases of DIGE associated with voclosporin, a newer calcineurin inhibitor used primarily to treat lupus nephritis.
Francesca Racca, Jessica M. Greco, Dimitris N. Tatakis   +2 more
wiley   +1 more source

Context-based task ontologies for clinical guidelines [PDF]

, 2004
Evidence-based medicine relies on the execution of clinical practice guidelines and protocols. A great deal of of effort has been invested in the development of various tools which automate the representation and execution of the recommendations ...
Ciccarese, Paolo, Kumar, Anand, Piazza, Matteo, Smith, Barry   +3 more
core  

Proteinuria in malignancy [PDF]

BMJ, 1988
P, Gosling, C P, Shearman, A J, Sutcliffe   +2 more
openaire   +2 more sources

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source

Recommendation of the Czech Nephrological Society and Czech Society of Clinical Biochemistry ČLS JEP for Examination of Proteinuria [PDF]

, 2011
Fyziologie, J Brinkman, S Bakker, R Gansevoort, W Comper, O Jerums, T Osicka, W Comper, T Osicka, M Engli, D Fliser, J Novak, V Thongboonkerd, B Friedeck, W Guder, W Hofmann, W Hofmann, B Rossmller, W Guder, H Ibsen, M Olsen, K Wachtell, M Ivandic, W Hofmann, W Guder, B Julian, H Suzuki, Y Suzuki, K/ Doqi, W Keane, G Eknoyan, Proteinuria, T Kouri, G Fogazzi, V Gant, E Lamb, F Mackenzie, P Stevens, M Mcqueen, H Gerstein, J Pogue, G Miller, D Bruns, G Hortin, N Ohisa, K Kanemitsu, R Matsuki, J Redon, R Rodby, R Rohde, Z Sharon, L Russo, W Comper, T Osicka, A Shaikh, J Segmiller, T Borland, V Teplan, V Tesa, L Vojtov, T Zima, L Thomas, V Thongboonkerd, K Mcleish, J Arthur, J Klein, D Wilson, R Anderson, J abka, O Viklick, S Dusilov-Sulkov, Autorsk Kolektiv ; Tesa, Zima Vladimr, Racek Tom, Teplan Jaroslav, Friedeck Vladimr, Kratochvla Bedich, Grantov Josef, Kubek Jana, Zdenek Doc, Mudr, Csc Romana Ryav   +81 more
openalex   +1 more source